With the volume and accessibility of scientific research increasing across the world, it has never been more important to continue building the reputation for quality and ethical publishing we’ve spent the past two centuries establishing. 1679-64-7, Name is 4-(Methoxycarbonyl)benzoic acid, SMILES is C1=CC(=CC=C1C(O)=O)C(OC)=O, in an article , author is Wu, Yan, once mentioned of 1679-64-7, Application In Synthesis of 4-(Methoxycarbonyl)benzoic acid.
Two series of [1,2,4]triazolo[3,4-a]phthalazine and tetrazolo[5,1-a]phthalazine derivatives bearing substituted benzylpiperazine moieties have been synthesized and evaluated for their positive inotropic activity by measuring left atrium stroke volume on isolated rabbit heart preparations. The majority of the derivatives exhibited better in vitro activity than the existing drug, milrinone, and 6-((4-(4-methoxyphenyl)piperazin-1-yl)methyl)tetrazolo[5,1-a]phthalazine. 8m in particular was identified as the most potent with an increased stroke volume of 12.02 +/- 0.20% (milrinone: 2.46 +/- 0.07%) at a concentration of 3x105m. The chronotropic effects of the compounds that exhibited good potency were also evaluated.
If you are hungry for even more, make sure to check my other article about 1679-64-7, Application In Synthesis of 4-(Methoxycarbonyl)benzoic acid.
Reference:
Phthalazine – Wikipedia,
,Phthalazine | C8H6N2 – PubChem